p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Journal of Biological Chemistry (Impact Factor: 4.6). 04/2009; 284(22):14939-48. DOI: 10.1074/jbc.M900097200
Source: PubMed

ABSTRACT Chaperonin containing TCP-1 (CCT) is a large multisubunit complex that mediates protein folding in eukaryotic cells. CCT participates in the folding of newly synthesized polypeptides, including actin, tubulin, and several cell cycle regulators; therefore, CCT plays an important role in cytoskeletal organization and cell division. Here we identify the chaperonin CCT as a novel physiological substrate for p90 ribosomal S6 kinase (RSK) and p70 ribosomal S6 kinase (S6K). RSK phosphorylates the beta subunit of CCT in response to tumor promoters or growth factors that activate the Ras-mitogen-activated protein kinase (MAPK) pathway. CCTbeta Ser-260 was identified as the RSK site by mass spectrometry and confirmed by site-directed mutagenesis. RSK-dependent Ser-260 phosphorylation was sensitive to the MEK inhibitor UO126 and the RSK inhibitor BID-1870. Insulin weakly activates RSK but strongly activates the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway and utilizes S6K to regulate CCTbeta phosphorylation. Thus, the Ras-MAPK and PI3K-mTOR pathways converge on CCTbeta Ser-260 phosphorylation in response to multiple agonists in various mammalian cells. We also show that RNA interference-mediated knockdown of endogenous CCTbeta causes impaired cell proliferation that can be rescued with ectopically expressed murine CCTbeta wild-type or phosphomimetic mutant S260D, but not the phosphorylation-deficient mutant S260A. Although the molecular mechanism of CCTbeta regulation remains unclear, our findings demonstrate a link between oncogene and growth factor signaling and chaperonin CCT-mediated cellular activities.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Trp-Asp (WD) repeat protein 68 (WDR68) is an evolutionarily conserved WD40-repeat protein that binds to several proteins including dual-specificity tYrosine-phosphorylation regulated protein kinase (DYRK1A), MAPK/ERK kinase kinase 1 (MEKK1), and cullin4-damage specific DNA binding protein 1 (CUL4-DDB1). WDR68 affects multiple and diverse physiological functions, such as controlling anthocyanin synthesis in plants, tissue growth in insects, and craniofacial development in vertebrates. However, the biochemical basis and the regulatory mechanism of WDR68 activity remain largely unknown. To better understand the cellular function of WDR68, here we have isolated and identified cellular WDR68-binding partners using a phospho-proteomic approach. More than 200 cellular proteins with wide varieties of biochemical functions were identified as WDR68-binding protein candidates. Eight T-complex protein 1 (TCP1) subunits comprising the molecular chaperone TCP1 ring complex/chaperonin containing TCP1 (TRiC/CCT) were identified as major WDR68-binding proteins, and phosphorylation sites in both WDR68 and TRiC/CCT were identified. Co-immunoprecipitation experiments confirmed the binding between TRiC/CCT and WDR68. Computer-aided structural analysis suggested that WDR68 forms a 7-bladed β-propeller ring. Experiments with a series of deletion mutants in combination with the structural modelling showed that 3 out of 7 of the β-propeller blades of WDR68 are essential and sufficient for TRiC/CCT-binding. Knockdown of cellular TRiC/CCT by siRNA caused an abnormal WDR68 structure and led to reduction of its DYRK1A-binding activity. Concomitantly, nuclear accumulation of WDR68 was suppressed by the knockdown of TRiC/CCT, and WDR68 formed cellular aggregates when overexpressed in the TRiC/CCT-deficient cells. Altogether, our results demonstrate that the molecular chaperone TRiC/CCT is essential for correct protein folding, DYRK1A-binding, and nuclear accumulation of WDR68.
    Journal of Biological Chemistry 10/2014; DOI:10.1074/jbc.M114.586115 · 4.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinase-3 (MMP-3) deficiency in mice was previously reported to result in a transiently retarded granule cell migration at postnatal day 8 (P8) and a sustained disturbed arborization of Purkinje cell dendrites from P8 on, concomitant with a delayed synapse formation between granule cells and Purkinje cells and resulting in mild deficits in motor performance in adult animals. However, the molecular mechanisms by which MMP-3 contributes to proper development of the cerebellar cortex during the first postnatal weeks remains unknown. In this study, we used a functional proteomics approach to investigate alterations in protein expression in postnatal cerebella of wild-type versus MMP-3 deficient mice, and to further elucidate MMP-3-dependent pathways and downstream targets in vivo. At P8, two-dimensional difference gel electrophoresis (2-D DIGE) and mass spectrometry identified 20 unique proteins with a different expression between the two genotypes. Subsequent ‘Ingenuity Pathway Analysis’ (IPA) analysis and Western blotting indicate that the chaperonin containing T-complex polypeptide 1, subunit 6A (CCT6a) and the MAP kinase signaling pathway play a key role in the MMP-3-dependent regulation of neurite outgrowth and neuronal migration in the developing brain. This article is protected by copyright. All rights reserved
    Developmental Neurobiology 02/2015; DOI:10.1002/dneu.22272 · 4.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Both ligand-dependent and ligand-independent activation of estrogen receptor (ER) α is modulated by receptor phosphorylation and results in activation of the ERα-dependent pathways that are involved in endometrioid endometrial cancer (EEC) pathogenesis. It is also known that the mammalian target of rapamycin (mTOR)/p70 S6 kinase 1 (S6K1) and mitogen-activated protein kinase (MAPK)/p90 ribosomal S6 kinase (RSK) signaling pathways coordinately regulate phosphorylated- ERα at Ser167 (p-Ser167-ERα). However, the expression of p-Ser167-ERα in EEC and its prognostic role in ECC is largely unexplored. The purpose of the present study was to investigate the expression of p-Ser167-ERα in ECC and its relationship with prognosis. Immunohistochemical staining of primary EEC surgical specimens (n=103) was carried out using antibodies specific for p-Ser167-ERα and for p-mTOR/p-S6K1 and p-MAPK/p-RSK. The correlation of p-Ser167-ERα expression with clinicopathological features and survival of ECC was studied. Patients that were positive for nuclear p-Ser167-ERα had significantly shorter relapse-free survival, and although the result was not significant, levels of nuclear p-Ser167-ERα tended to be higher in advanced-stage ECC patients. Nuclear p-Ser167-ERα was significantly positively correlated with p-MAPK and p-S6K1, and with significantly shorter relapse-free survival in EEC.This article is protected by copyright. All rights reserved.
    Cancer Science 08/2014; 105(10). DOI:10.1111/cas.12491 · 3.53 Impact Factor